Skip to main content
. 2022 Feb 19;3(2):406–424. doi: 10.1007/s42761-021-00098-y

Table 1.

Demographic information and descriptive statistics for participants with and without follow-up data

Characteristics Full sample (N =176) Follow-up (N = 145)
Women (%) 50.6 53.4
Age (years) 40.1 ± 6.3 40.4 ± 6.1
Race and ethnicity (%)
    White 68.8 71.0
    Black/African American 26.1 25.5
    Asian/Asian American 4.0 2.1
    Multiracial 0.6 0.7
    Other 0.6 0.7
Number of school years completed 16.3 ± 3.3 16.3 ± 3.2
Smoking status (%)
    Never smoked 61.4 66.2
    Former smoker 19.9 19.3
    Current smoker 18.8 14.5
Number of drinks in the last week 3.1 ± 4.6 3.0 ± 4.2
Body mass index (kg/m2) 26.7 ± 5.2 26.8 ± 5.5
Waist circumference (in) 35.2 ± 5.5 35.4 ± 5.6
Total cholesterol (mg/dL) 183 ± 33.9 184 ± 33.0
Triglycerides (mg/dL) 95.7± 56.3 95.2 ± 59.0
HDL (mg/dL) 51.8 ± 15.8 51.7 ± 13.6
LDL (mg/dL) 113.0 ± 27.7 114.0 ± 28.0
Glucose (mg/dL) 88.6 ± 8.6 88.9 ± 8.7
Systolic blood pressure (mmHg) 120.0 ± 11.4 120.0 ± 11.7
Diastolic blood pressure (mmHg) 71.0 ± 9.5 71.2 ± 9.4
Heart rate (bpm) 77.4 ± 11.6 77.4 ± 11.2
Framingham 10-year risk score (%) 1.1 ± 2.1 1.2 ± 2.2
“Look Neutral” rating (1–5) 1.3, 95% CI [1.2, 1.3] 1.2, 95% CI [1.2, 1.3]
“Look Negative” rating (1–5) 3.6, 95% CI [3.5, 3.7] 3.7, 95% CI [3.6, 3.7]
“Regulate Negative” rating (1–5) 3.1, 95% CI [3.0, 3.2] 3.1, 95% CI [3.0, 3.2]
“Look Negative” – “Look Neutral” 2.4, 95% CI [2.3, 2.5] 2.4, 95% CI [2.3, 2.5]
“Regulate Negative” – “Look Negative” − 0.5, 95% CI [− 0.6, − 0.4] − 0.5, 95% CI [− 0.6, − 0.4]
Mean CCA IMT (mm) 0.58 ± 0.10 0.58 ± 0.10
Annual progression of mean CCA IMT (mm/yr) - 0.0056 ± 0.0229
Annual progression of mean of the maximum IMT at site of fastest progression - 0.0904 ± 0.117